Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study

Background: The evidence of the long-term advantages of transcatheter aortic valve replacement (TAVR) over surgical aortic valve replacement (SAVR) for aortic stenosis (AS) remains scarce. Methods: Patients with EuroSCORE II < 4 % who underwent TAVR or SAVR for AS from the prospective observation...

Full description

Saved in:
Bibliographic Details
Main Authors: Fausto Biancari, Paola D’Errigo, Marco Barbanti, Gabriella Badoni, Corrado Tamburino, Gianluca Polvani, Giuliano Costa, Giovanni Baglio, Stefano Rosato
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906724002112
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850220586826989568
author Fausto Biancari
Paola D’Errigo
Marco Barbanti
Gabriella Badoni
Corrado Tamburino
Gianluca Polvani
Giuliano Costa
Giovanni Baglio
Stefano Rosato
author_facet Fausto Biancari
Paola D’Errigo
Marco Barbanti
Gabriella Badoni
Corrado Tamburino
Gianluca Polvani
Giuliano Costa
Giovanni Baglio
Stefano Rosato
author_sort Fausto Biancari
collection DOAJ
description Background: The evidence of the long-term advantages of transcatheter aortic valve replacement (TAVR) over surgical aortic valve replacement (SAVR) for aortic stenosis (AS) remains scarce. Methods: Patients with EuroSCORE II < 4 % who underwent TAVR or SAVR for AS from the prospective observational OBSERVANT study were included in this analysis. Ten-year survival was the primary outcome of this analysis. Secondary outcome was repeat procedure on the aortic valve prosthesis. Results: Propensity score matching resulted in 355 matched pairs of patients who underwent TAVR or SAVR. The mean age of SAVR patients was 80.0 ± 5.1 years and that of TAVR patients 80.1 ± 6.4 years (p = 0.81) and the mean EuroSCORE II was 2.5 ± 0.8 % and 2.6 ± 0.8 % (p = 0.60), respectively. Thirty-day mortality was 2.8 % after SAVR and 2.5 % after TAVR (p = 0.82). At 10-year, survival was 37.0 % (95 %CI 32.2–42.5 %) after SAVR and 18.2 % (95 %CI 14.5–22.8 %) after TAVR (Log-rank test, p < 0.001; HR 1.70, 95 %CI 1.42–2.03). Difference in terms of survival between the propensity matched cohorts became significant 3 years after the procedures. Ten-year cumulative incidences of repeat aortic valve procedure were 2.6 % (95 %CI 1.4–5.0 %) after SAVR and 1.1 % (95 %CI 0.4–3.0 %) after TAVR (p = 0.153; SHR 0.43, 95 %CI 0.13–1.41). Conclusions: The results of this prospective observational, non-randomized study showed that 10-year survival of low-risk patients who underwent TAVR with early generation prosthesis devices was lower than SAVR.
format Article
id doaj-art-d2c4a7ffae2c4386be4e87572acdfb8c
institution OA Journals
issn 2352-9067
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj-art-d2c4a7ffae2c4386be4e87572acdfb8c2025-08-20T02:07:01ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672024-12-015510154510.1016/j.ijcha.2024.101545Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT studyFausto Biancari0Paola D’Errigo1Marco Barbanti2Gabriella Badoni3Corrado Tamburino4Gianluca Polvani5Giuliano Costa6Giovanni Baglio7Stefano Rosato8Department of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan, Italy; Corresponding author at: Department of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan 20138, Italy.National Center for Global Health, Istituto Superiore di Sanitá, Rome, ItalyUniversità degli Studi di Enna “Kore”, Enna, Italy; Division of Cardiology, Ospedale Umberto I, ASP 4 di Enna, Enna, ItalyNational Center for Global Health, Istituto Superiore di Sanitá, Rome, ItalyDivision of Cardiology, Azienda Ospedaliera Universitaria Policlinico “G. Rodolico-San Marco”, Catania, ItalyDepartment of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, ItalyDivision of Cardiology, Azienda Ospedaliera Universitaria Policlinico “G. Rodolico-San Marco”, Catania, ItalyItalian National Agency for Regional Healthcare Services, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanitá, Rome, ItalyBackground: The evidence of the long-term advantages of transcatheter aortic valve replacement (TAVR) over surgical aortic valve replacement (SAVR) for aortic stenosis (AS) remains scarce. Methods: Patients with EuroSCORE II < 4 % who underwent TAVR or SAVR for AS from the prospective observational OBSERVANT study were included in this analysis. Ten-year survival was the primary outcome of this analysis. Secondary outcome was repeat procedure on the aortic valve prosthesis. Results: Propensity score matching resulted in 355 matched pairs of patients who underwent TAVR or SAVR. The mean age of SAVR patients was 80.0 ± 5.1 years and that of TAVR patients 80.1 ± 6.4 years (p = 0.81) and the mean EuroSCORE II was 2.5 ± 0.8 % and 2.6 ± 0.8 % (p = 0.60), respectively. Thirty-day mortality was 2.8 % after SAVR and 2.5 % after TAVR (p = 0.82). At 10-year, survival was 37.0 % (95 %CI 32.2–42.5 %) after SAVR and 18.2 % (95 %CI 14.5–22.8 %) after TAVR (Log-rank test, p < 0.001; HR 1.70, 95 %CI 1.42–2.03). Difference in terms of survival between the propensity matched cohorts became significant 3 years after the procedures. Ten-year cumulative incidences of repeat aortic valve procedure were 2.6 % (95 %CI 1.4–5.0 %) after SAVR and 1.1 % (95 %CI 0.4–3.0 %) after TAVR (p = 0.153; SHR 0.43, 95 %CI 0.13–1.41). Conclusions: The results of this prospective observational, non-randomized study showed that 10-year survival of low-risk patients who underwent TAVR with early generation prosthesis devices was lower than SAVR.http://www.sciencedirect.com/science/article/pii/S2352906724002112Aortic valve stenosisTranscatheter aortic valve replacementTAVRSAVRlow risk
spellingShingle Fausto Biancari
Paola D’Errigo
Marco Barbanti
Gabriella Badoni
Corrado Tamburino
Gianluca Polvani
Giuliano Costa
Giovanni Baglio
Stefano Rosato
Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
International Journal of Cardiology: Heart & Vasculature
Aortic valve stenosis
Transcatheter aortic valve replacement
TAVR
SAVR
low risk
title Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
title_full Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
title_fullStr Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
title_full_unstemmed Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
title_short Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study
title_sort ten year outcomes after transcatheter or surgical aortic valve replacement in low risk patients the observant study
topic Aortic valve stenosis
Transcatheter aortic valve replacement
TAVR
SAVR
low risk
url http://www.sciencedirect.com/science/article/pii/S2352906724002112
work_keys_str_mv AT faustobiancari tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT paoladerrigo tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT marcobarbanti tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT gabriellabadoni tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT corradotamburino tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT gianlucapolvani tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT giulianocosta tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT giovannibaglio tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy
AT stefanorosato tenyearoutcomesaftertranscatheterorsurgicalaorticvalvereplacementinlowriskpatientstheobservantstudy